Tag: Harold Chatelus

Rohatyn Group completes investment in Croatian CRO Optimapharm

pharmanewsdaily- May 13, 2020

The Rohatyn Group (TRG), a US asset management firm focusing on emerging markets, has completed an investment in Optimapharm, a contract research organization (CRO) based ... Read More